Overexpression of ROD1 inhibits invasion of breast cancer cells by suppressing the translocation of β‑catenin into the nucleus

Zhou,Ya; Zou,Hanqing; Wu,Enhao; Huang,Lei; Yin,Rui; Mei ,Yuxin; Zhu,Xun

doi:10.3892/ol.2018.8917

Overexpression of ROD1 inhibits invasion of breast cancer cells by suppressing the translocation of β‑catenin into the nucleus

Authors:
- Ya Zhou
- Hanqing Zou
- Enhao Wu
- Lei Huang
- Rui Yin
- Yuxin Mei
- Xun Zhu
View Affiliations

Affiliations: Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China
Published online on: June 6, 2018 https://doi.org/10.3892/ol.2018.8917
Pages: 2645-2653

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The incidence of breast cancer is increasing throughout the world. Although significant progress has been made in diagnostic techniques and targeted therapies, the prognosis of breast cancer remains poor. Regulator of differentiation 1 (ROD1) may inhibit the development of several types of cancer. However, the role of ROD1 in breast cancer cells remains unknown. In the present study, western blot analysis and reverse transcription‑quantitative polymerase chain reaction revealed that expression of ROD1 was significantly reduced in breast cancer cells. Overexpression of ROD1 reduced the proliferation rate, demonstrated using a Cell Counting Kit‑8 assay. Additionally, the overexpression of ROD1 decreased the invasiveness of breast cancer cells, indicating that ROD1 may serve as a tumor suppressor. Additionally, the data suggested that ROD1 significantly suppressed the activity of Wnt luciferase reporter (TOP Flash) in MDA‑MB‑231 cells. Furthermore, it was demonstrated that ROD1 may interact with β‑catenin by using co‑immunoprecipitation, resulting in suppression of β‑catenin migration into the nucleus. Notably, ROD1 demonstrated its anticancer effect by decreasing β‑catenin (Y333) phosphorylation in a nude mouse xenograft model. Overexpression of ROD1 may downregulate Ki67 protein levels, as determined by immunohistochemistry. These results indicated that ROD1 may be used as a therapeutic target in patients with breast cancer.

View Figures

View References

1	DeSantis C, Ma JM, Bryan L and Jemal A: Breast Cancer Statistics, 2013. CA Cancer J Clin. 64:52–62. 2014. View Article : Google Scholar : PubMed/NCBI
2	Polakis P: The oncogenic activation of beta-catenin. Curr Opin Genet Dev. 9:15–21. 1999. View Article : Google Scholar : PubMed/NCBI
3	Howe LR and Brown AM: Wnt signaling and breast cancer. Cancer Biol Ther. 3:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
4	Incassati A, Chandramouli A, Eelkema R and Cowin P: Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res. 12:122010
5	Lin SY, Xia WY, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG and Hung MC: beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000. View Article : Google Scholar : PubMed/NCBI
6	Behrens J: Control of beta-catenin signaling in tumor development. Ann Ny Acad Sci. 910:21–35. 2000. View Article : Google Scholar : PubMed/NCBI
7	Holland JD, Klaus A, Garratt AN and Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
8	Turashvili G, Bouchal J, Burkadze G and Kolar Z: Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology. 73:213–223. 2006. View Article : Google Scholar : PubMed/NCBI
9	Verras M and Sun ZJ: Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett. 237:22–32. 2006. View Article : Google Scholar : PubMed/NCBI
10	Amado NG, Fonseca BF, Cerqueira DM, Neto VM and Abreu JG: Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 89:545–554. 2011. View Article : Google Scholar : PubMed/NCBI
11	Yamamoto H, Tsukahara K, Kanaoka Y, Jinno S and Okayama H: Isolation of a mammalian homologue of a fission yeast differentiation regulator. Mol Cell Biol. 19:3829–3841. 1999. View Article : Google Scholar : PubMed/NCBI
12	Spellman R, Llorian M and Smith CW: Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell. 27:420–434. 2007. View Article : Google Scholar : PubMed/NCBI
13	Maniatis T and Tasic B: Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature. 418:236–243. 2002. View Article : Google Scholar : PubMed/NCBI
14	Hagen RM and Ladomery MR: Role of splice variants in the metastatic progression of prostate cancer. Biochem Soc Trans. 40:870–874. 2012. View Article : Google Scholar : PubMed/NCBI
15	Brazao TF, Demmers J, van IJcken W, Strouboulis J, Fornerod M, Romão L and Grosveld FG: A new function of ROD1 in nonsense-mediated mRNA decay. FEBS Lett. 586:1101–1110. 2012. View Article : Google Scholar : PubMed/NCBI
16	Chen B, Zhao AG, Shao J, Mu XY, Jiang L and Liu JW: The effects of PTBP3 silencing on the proliferation and differentiation of MKN45 human gastric cancer cells. Life Sci. 114:29–35. 2014. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol for rapid generation of recombinant adenoviruses using the Ad Easy system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
19	Lv K, Guo YJ, Zhang YL, Wang K, Li K, Zhu Y and Sun S: Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region. Res Vet Sci. 86:443–452. 2009. View Article : Google Scholar : PubMed/NCBI
20	Anderson RD, Haskell RE, Xia H, Roessler BJ and Davidson BL: A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther. 7:1034–1038. 2000. View Article : Google Scholar : PubMed/NCBI
21	Lu FI, Sun YH, Wei CY, Thisse C and Thisse B: Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway. Nat Commun. 5:53682014. View Article : Google Scholar : PubMed/NCBI
22	Gaspar C and Fodde R: APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol. 48:377–386. 2004. View Article : Google Scholar : PubMed/NCBI
23	Chen GP, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma-Potential pathogenetic and prognostic implications. Cancer. 101:1345–1356. 2004. View Article : Google Scholar : PubMed/NCBI
24	Yang F, Zeng Q, Yu G, Li S and Wang CY: Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal. 18:679–687. 2006. View Article : Google Scholar : PubMed/NCBI
25	Fiebig HH, Berger DP, Winterhalter BR and Plowman J: In vitro and In vivo evaluation of Us-Nci compounds in human tumor xenografts. Cancer Treat Rev. 17:109–117. 1990. View Article : Google Scholar : PubMed/NCBI
26	Zhang D, Fei F, Li S, Zhao Y, Yang Z, Qu J, Zhang X, Yin Y and Zhang S: The role of β-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer. J Cancer. 8:2114–2123. 2017. View Article : Google Scholar : PubMed/NCBI
27	Sun B, Zhang S, Zhang D, Liu Y, Li Y, Rong Z, Zhu Y and Jia X: Clusterin is associated with spontaneous breast cancer in TA2 mice. FEBS Lett. 581:3277–3282. 2007. View Article : Google Scholar : PubMed/NCBI
28	Lindvall C, Evans NC, Zylstra CR, Li Y, Alexander CM and Williams BO: The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem. 281:35081–35087. 2006. View Article : Google Scholar : PubMed/NCBI
29	Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
30	Rosano L, Cianfrocca R, Spinella F, Di Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG and Bagnato A: Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res. 17:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI